Spatial distribution of the trace elements zinc, strontium and lead in human bone tissue

Bone

Volumn 57, Issue 1, 2013, Pages 184-193

  Pemmer, B ^a   Roschger, A ^a,b   Wastl, A ^a   Hofstaetter, J G ^b,c   Wobrauschek, P ^a   Simon, R ^d   Thaler, H W ^e   Roschger, P ^b   Klaushofer, K ^b   Streli, C ^a  

^a VIENNA UNIVERSITY OF TECHNOLOGY   (Austria)

^b HANUSCH HOSPITAL   (Austria)

^c ORTHOPAEDIC HOSPITAL SPEISING   (Austria)

^d KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

^e AUVA Trauma Centre Meidling   (Austria)

Author keywords

Human bone; Quantitative backscattered electron imaging; Spatial distribution; Synchrotron radiation micro X ray fluorescence analysis; Trace elements

Indexed keywords

CALCIUM; LEAD; STRONTIUM; ZINC;

AGED; ARTICLE; BIOACCUMULATION; BONE MATRIX; BONE METABOLISM; BONE MINERALIZATION; BONE STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FEMUR NECK; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMAGE PROCESSING; QUANTITATIVE ANALYSIS; SCANNING ELECTRON MICROSCOPY; SYNCHROTRON RADIATION; TISSUE DISTRIBUTION; TISSUE LEVEL; X RAY FLUORESCENCE;

HUMAN BONE; QUANTITATIVE BACKSCATTERED ELECTRON IMAGING; SPATIAL DISTRIBUTION; SYNCHROTRON RADIATION MICRO X-RAY FLUORESCENCE ANALYSIS; TRACE ELEMENTS;

AGED; AGED, 80 AND OVER; BONE AND BONES; FEMALE; HUMANS; LEAD; POSTMENOPAUSE; STRONTIUM; TRACE ELEMENTS; ZINC;

EID: 84883285817     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2013.07.038     Document Type: Article

References (98)

1. Sky-Peck H.H., Joseph B.J. Determination of trace elements in human serum by energy dispersive X-ray fluorescence. Clin Biochem 1981, 14:126-131.
2. Aaseth J., Boivin G., Andersen O. Osteoporosis and trace elements-an overview. J Trace Elem Med Biol 2012, 26:149-152.
3. Chettle D.R., Scott M.C., Somervaille L.J. Lead in bone: sampling and quantitation using K X-rays excited by 109Cd. Environ Health Perspect 1991, 91:49-55.
4. Rosen J.F., Crocetti A.F., Balbi K., Balbi J., Bailey C., Clemente I., et al. Bone lead content assessed by L-line X-ray fluorescence in lead-exposed and non-lead-exposed suburban populations in the United States. Proc Natl Acad Sci U S A 1993, 90:2789-2792.
5. Takata M.K., Saiki M., Sumita N.M., Saldiva P.H.N., Pasqualucci C.A. Activation analysis methods and applications: trace element determinations in human cortical and trabecular bones. J Radioanal Nucl Chem 2005, 264:5-8.
6. Zhang Y., Cheng F., Li D., Wang Y., Zhang G., Liao W., et al. Investigation of elemental content distribution in femoral head slice with osteoporosis by SRXRF microprobe. Biol Trace Elem Res 2005, 103:177-185.
7. Carvalho M.L., Marques A.F., Lima M.T., Reus U. Trace elements distribution and post-mortem intake in human bones from middle age by total reflection X-ray fluorescence. Spectrochim Acta B At Spectrosc 2004, 59:1251-1257.
8. Samudralwar D., Robertson J. Determination of major and trace elements in bones by simultaneous PIXE/PIGE analysis. J Radioanal Nucl Chem 1993, 169:259-267.
9. Bellis D.J., Li D., Chen Z., Gibson W.M., Parsons P.J. Measurement of the microdistribution of strontium and lead in bone via benchtop monochromatic microbeam X-ray fluorescence with a low power source. J Anal At Spectrom 2009, 24:622-626.
10. Lima I., Anjos M.J., Fleiuss M.L.F., Rosenthal D., Lopes R.T. Characterization of osteoporotic bone structures by bidimensional images through X-ray microfluorescence with synchrotron radiation. X-Ray Spectrom 2008, 37:249-254.
11. Zoeger N., Roschger P., Hofstaetter J.G., Jokubonis C., Pepponi G., Falkenberg G., et al. Lead accumulation in tidemark of articular cartilage. Osteoarthritis Cartilage 2006, 14:906-913.
12. Roschger A., Hofstaetter J.G., Pemmer B., Zoeger N., Wobrauschek P., Falkenberg G., et al. Differential accumulation of lead and zinc in double-tidemarks of articular cartilage. Osteoarthr Cartil 2013, http://dx.doi.org/10.1016/j.joca.2013.06.029 (in press).
13. Van Grieken R., Markowicz A. Handbook of X-ray spectrometry 2002, Marcel Dekker Inc., New York, Basel.
14. Kawade R. Zinc status and its association with the health of adolescents: a review of studies in India. Glob Health Action 2012, 5:7353.
15. Ito A., Kawamura H., Otsuka M., Ikeuchi M., Ohgushi H., Ishikawa K., et al. Zinc-releasing calcium phosphate for stimulating bone formation. Mater Sci Eng C 2002, 22:21-25.
16. Kaji M., Nishi Y. Growth and minerals: zinc. Growth Genet Hormon 2006, 22:1-7.
17. Maser R.E., Stabley J.N., Lenhard M.J., Owusu-Griffin P., Provost-Craig M.A., Farquhar W.B. Zinc intake and biochemical markers of bone turnover in type 1 diabetes. Diabetes Care 2008, 31:2279-2280.
18. Aitken J. Factors affecting the distribution of zinc in the human skeleton. Calcif Tissue Int 1976, 20:23-30.
19. Sandstead H.H., Prasad A.S., Schulert A.R., Farid Z., Miale A., Bassilly S., et al. Human zinc deficiency, endocrine manifestations and response to treatment. Am J Clin Nutr 1967, 20:422-442.
20. Mentaverri R., Brazier M., Kamel S., Fardellone P. Potential anti-catabolic and anabolic properties of strontium ranelate. Curr Mol Pharmacol 2012, 5:189-194.
21. Jarup L. Hazards of heavy metal contamination. Br Med Bull 2003, 68:167-182.
22. Tsaih S.W., Korrick S., Schwartz J., Lee M.L., Amarasiriwardena C., Aro A., et al. Influence of bone resorption on the mobilization of lead from bone among middle-aged and elderly men: the Normative Aging Study. Environ Health Perspect 2001, 109:995-999.
23. Sun Y., Sun D., Zhou Z., Zhu G., Zhang H., Chang X., et al. Osteoporosis in a Chinese population due to occupational exposure to lead. Am J Ind Med 2008, 51:436-442.
24. Nelson A.E., Shi X.A., Schwartz T.A., Chen J.C., Renner J.B., Caldwell K.L., et al. Whole blood lead levels are associated with radiographic and symptomatic knee osteoarthritis: a cross-sectional analysis in the Johnston County Osteoarthritis Project. Arthritis Res Ther 2011, 13:R37.
25. Barry P.S. A comparison of concentrations of lead in human tissues. Br J Ind Med 1975, 32:119-139.
26. Roschger P., Paschalis E.P., Fratzl P., Klaushofer K. Bone mineralization density distribution in health and disease. Bone 2008, 42:456-466.
27. Skedros J.G., Holmes J.L., Vajda E.G., Bloebaum R.D. Cement lines of secondary osteons in human bone are not mineral-deficient: new data in a historical perspective. Anat Rec A Discov Mol Cell Evol Biol 2005, 286A:781-803.
28. Ruffoni D., Fratzl P., Roschger P., Klaushofer K., Weinkamer R. The bone mineralization density distribution as a fingerprint of the mineralization process. Bone 2007, 40:1308-1319.
29. Loveridge N., Power J., Reeve J., Boyde A. Bone mineralization density and femoral neck fragility. Bone 2004, 35:929-941.
30. Fratzl-Zelman N., Roschger P., Gourrier A., Weber M., Misof B.M., Loveridge N., et al. Combination of nanoindentation and quantitative backscattered electron imaging revealed altered bone material properties associated with femoral neck fragility. Calcif Tissue Int 2009, 85:335-343.
31. Roschger P., Fratzl P., Eschberger J., Klaushofer K. Validation of quantitative backscattered electron imaging for the measurement of mineral density distribution in human bone biopsies. Bone 1998, 23:319-326.
32. Pemmer B., Hofstaetter J.G., Meirer F., Smolek S., Wobrauschek P., Simon R., et al. Increased strontium uptake in trabecular bone of ovariectomized calcium-deficient rats treated with strontium ranelate or strontium chloride. J Synchrotron Radiat 2011, 18:835-841.
33. Gupta H.S., Schratter S., Tesch W., Roschger P., Berzlanovich A., Schoeberl T., et al. Two different correlations between nanoindentation modulus and mineral content in the bone-cartilage interface. J Struct Biol 2005, 149:138-148.
34. Fratzl-Zelman N., Roschger P., Gourrier A., Weber M., Misof B., Loveridge N., et al. Combination of nanoindentation and quantitative backscattered electron imaging revealed altered bone material properties associated with femoral neck fragility. Calcif Tissue Int 2009, 85:335-343.
35. Goldstein J.I. Scanning electron microscopy and X-ray microanalysis 1992, Plenum Press, New York. 2nd ed.
36. Zoeger N., Streli C., Wobrauschek P., Jokubonis C., Pepponi G., Roschger P., et al. Determination of the elemental distribution in human joint bones by SR micro XRF. X-Ray Spectrom 2008, 37:3-11.
37. Zoeger N., Wobrauschek P., Streli C., Pepponi G., Roschger P., Falkenberg G., et al. Distribution of Pb and Zn in slices of human bone by synchrotron μ-XRF. X-ray Spectrom 2005, 140-143.
38. Janssens K., Proost K., Falkenberg G. Confocal microscopic X-ray fluorescence at the HASYLAB microfocus beamline: characteristics and possibilities. Spectrochim Acta B Atomic Spectrosc 2004, 59:1637-1645.
39. Kanngießer B., Malzer W., Reiche I. A new 3D micro X-ray fluorescence analysis set-up-first archaeometric applications. Nucl Instrum Methods Phys Res, Sect B 2003, 211:259-264.
40. Simon R., Buth G., Hagelstein M. The X-ray-fluorescence facility at ANKA, Karlsruhe: minimum detection limits and micro probe capabilities. Nucl Instrum Methods Phys Res, Sect B 2003, 199:554-558.
41. Simon R., Kerdpin U., Friedrich F., Faubel W., Weidler P.G., Nüesch R. Depth resolved X-ray fluorescence analysis of copper charged muscovite mica. Adv X-ray Anal 2007, 50:64-70.
42. Vincze L., Vekemans B., Brenker F.E., Falkenberg G., Rickers K., Somogyi A., et al. Three-dimensional trace element analysis by confocal X-ray microfluorescence imaging. Anal Chem 2004, 76:6786-6791.
43. Rasband W. ImageJ - image processing and analysis in Java (v1.44c) 2011, National Institutes of Health, Bethesda, Maryland, USA.
44. Dowd T.L., Rosen J.F., Mints L., Gundberg C.M. The effect of Pb(2+) on the structure and hydroxyapatite binding properties of osteocalcin. Biochim Biophys Acta 2001, 1535:153-163.
45. Dowd T.L., Rosen J.F., Gundberg C.M., Gupta R.K. The displacement of calcium from osteocalcin at submicromolar concentrations of free lead. Biochim Biophys Acta 1994, 1226:131-137.
46. Krane S.M., Inada M. Matrix metalloproteinases and bone. Bone 2008, 43:7-18.
47. Bonner F.W., King L.J., Parke D.V. Cadmium-induced reduction of bone alkaline phosphatase and its prevention by zinc. Chem Biol Interact 1980, 29:369-372.
48. Brzoska M.M., Rogalska J., Galazyn-Sidorczuk M., Jurczuk M., Roszczenko A., Kulikowska-Karpinska E., et al. Effect of zinc supplementation on bone metabolism in male rats chronically exposed to cadmium. Toxicology 2007, 237:89-103.
49. Iwami K., Moriyama T. Comparative effect of cadmium on osteoblastic cells and osteoclastic cells. Arch Toxicol 1993, 67:352-357.
50. Meunier N., O'Connor J.M., Maiani G., Cashman K.D., Secker D.L., Ferry M., et al. Importance of zinc in the elderly: the ZENITH study. Eur J Clin Nutr 2005, 59(Suppl. 2):S1-S4.
51. Yamaguchi M. Role of zinc in bone formation and bone resorption. J Trace Elem Exp Med 1998, 11:119-135.
52. Beattie J.H., Avenell A. Trace element nutrition and bone metabolism. Nutr Res Rev 1992, 5:167-188.
53. Murray E.J., Messer H.H. Turnover of bone zinc during normal and accelerated bone loss in rats. J Nutr 1981, 111:1641-1647.
54. Sherman S.S., Smith J.C., Tobin J.D., Soares J.H. Ovariectomy, dietary zinc, and bone metabolism in retired breeder rats. Am J Clin Nutr 1989, 49:1184-1191.
55. Pors Nielsen S. The biological role of strontium. Bone 2004, 35:583-588.
56. Walser M. Renal excretion of alkaline earths. Mineral metabolism. An advanced treatise 1969, 235-320. Academic Press, New York. C.L. Comar, F. Bronner (Eds.).
57. Roschger P., Manjubala I., Zoeger N., Meirer F., Simon R., Li C., et al. Bone material quality in transiliac bone biopsies of postmenopausal osteoporotic women after 3years of strontium ranelate treatment. J Bone Miner Res 2010, 25:891-900.
58. Li C., Paris O., Siegel S., Roschger P., Paschalis E.P., Klaushofer K., et al. Strontium is incorporated into mineral crystals only in newly formed bone during strontium ranelate treatment. J Bone Miner Res 2010, 25:968-975.
59. Busselberg D., Evans M.L., Rahmann H., Carpenter D.O. Lead and zinc block a voltage-activated calcium channel of Aplysia neurons. J Neurophysiol 1991, 65:786-795.
60. Schirrmacher K., Wiemann M., Bingmann D., Busselberg D. Effects of lead, mercury, and methyl mercury on gap junctions and [Ca2+]i in bone cells. Calcif Tissue Int 1998, 63:134-139.
61. Bres E.F., Voegel J.C., Barry J.C., Waddington W.G., Frank R.M. Feasibility study for the detection of lead substitution sites in the hydroxyapatite crystal structure using high-resolution electron microscopy (HREM) at optimum focus. J Appl Crystallogr 1986, 19:168-173.
62. 2+ ion-exchanged apatites by X-ray powder pattern-fitting. J Solid State Chem 1986, 61:230-235.
63. Pounds J.G., Long G.J., Rosen J.F. Cellular and molecular toxicity of lead in bone. Environ Health Perspect 1991, 91:17-32.
64. Verbeeck R.M., Lassuyt C.J., Heijligers H.J., Driessens F.C., Vrolijk J.W. Lattice parameters and cation distribution of solid solutions of calcium and lead hydroxyapatite. Calcif Tissue Int 1981, 33:243-247.
65. Fuchs R.K., Allen M.R., Condon K.W., Reinwald S., Miller L.M., McClenathan D., et al. Strontium ranelate does not stimulate bone formation in ovariectomized rats. Osteoporos Int 2008, 19:1331-1341.
66. Boivin G., Deloffre P., Perrat B., Panczer G., Boudeulle M., Mauras Y., et al. Strontium distribution and interactions with bone mineral in monkey iliac bone after strontium salt (S 12911) administration. J Bone Miner Res 1996, 11:1302-1311.
67. Dahl S.G., Allain P., Marie P.J., Mauras Y., Boivin G., Ammann P., et al. Incorporation and distribution of strontium in bone. Bone 2001, 28:446-453.
68. Farlay D., Boivin G., Panczer G., Lalande A., Meunier P.J. Long-term strontium ranelate administration in monkeys preserves characteristics of bone mineral crystals and degree of mineralization of bone. J Bone Miner Res 2005, 20:1569-1578.
69. Ellis D.E., Terra J., Warschkow O., Jiang M., González G.B., Okasinski J.S., et al. A theoretical and experimental study of lead substitution in calcium hydroxyapatite. Phys Chem Chem Phys 2006, 8:967-976.
70. Ma Q.Y., Traina S.J., Logan T.J., Ryan J.A. In situ lead immobilization by apatite. Environ Sci Technol 1993, 27:1803-1810.
71. Ma Q.Y., Traina S.J., Logan T.J., Ryan J.A. Effects of aqueous Al, Cd, Cu, Fe(II), Ni, and Zn on Pb immobilization by hydroxyapatite. Environ Sci Technol 1994, 28:1219-1228.
72. Xu Y., Schwartz F.W. Lead immobilization by hydroxyapatite in aqueous solutions. J Contam Hydrol 1994, 15:187-206.
73. Meski S., Khireddine H., Ziani S., Rengaraj S., Sillanpää M. Comparative study on the removal of zinc(II) by bovine bone, billy goat bone and synthetic hydroxyapatite. Desalin Water Treat 2010, 16:271-281.
74. Feng Y., Gong J.-L., Zeng G.-M., Niu Q.-Y., Zhang H.-Y., Niu C.-G., et al. Adsorption of Cd (II) and Zn (II) from aqueous solutions using magnetic hydroxyapatite nanoparticles as adsorbents. Chem Eng J 2010, 162:487-494.
75. 2+ ions from groundwater using hydroxyapatite nanoparticles. Rev Chim 2011, 62.
76. Chaturvedi P.K., Seth C.S., Misra V. Sorption kinetics and leachability of heavy metal from the contaminated soil amended with immobilizing agent (humus soil and hydroxyapatite). Chemosphere 2006, 64:1109-1114.
77. Bigi A., Ripamonti A., Bruckner S., Gazzano M., Roveri N., Thomas S.A. Structure refinements of lead-substituted calcium hydroxyapatite by X-ray powder fitting. Acta Crystallogr B 1989, 45:247-251.
78. Brückner S., Lusvardi G., Menabue L., Saladini M. Crystal structure of lead hydroxyapatite from powder X-ray diffraction data. Inorg Chim Acta 1995, 236:209-212.
79. Meirer F., Pemmer B., Pepponi G., Zoeger N., Wobrauschek P., Sprio S., et al. Assessment of chemical species of lead accumulated in tidemarks of human articular cartilage by X-ray absorption near-edge structure analysis. J Synchrotron Radiat 2011, 18:238-244.
80. Davies D.R., Bassingthwaighte J.B., Kelly P.J. Transcapillary exchange of strontium and sucrose in canine tibia. J Appl Physiol 1976, 40:17-22.
81. Calhoun N.R., Smith J.C., Becker K.L. The role of zinc in bone metabolism. Clin Orthop Relat Res 1974, 212-234.
82. Lappalainen R., Knuuttila M., Lammi S., Alhava E.M., Olkkonen H. Zn and Cu content in human cancellous bone. Acta Orthop Scand 1982, 53:51-55.
83. Tang Y., Chappell H.F., Dove M.T., Reeder R.J., Lee Y.J. Zinc incorporation into hydroxyapatite. Biomaterials 2009, 30:2864-2872.
84. Matsunaga K., Murata H., Mizoguchi T., Nakahira A. Mechanism of incorporation of zinc into hydroxyapatite. Acta Biomater 2010, 6:2289-2293.
85. Escribano A., Revilla M., Hernandez E.R., Seco C., Gonzalez-Riola J., Villa L.F., et al. Effect of lead on bone development and bone mass: a morphometric, densitometric, and histomorphometric study in growing rats. Calcif Tissue Int 1997, 60:200-203.
86. Miyahara T., Komiyama H., Miyanishi A., Takata M., Nagai M., Kozuka H., et al. Stimulative effects of lead on bone resorption in organ culture. Toxicology 1995, 97:191-197.
87. 2+ on cultured osteoblastic bone cells. J Biol Chem 1990, 265:20833-20838.
88. Klein R.F., Wiren K.M. Regulation of osteoblastic gene expression by lead. Endocrinology 1993, 132:2531-2537.
89. Long G.J., Rosen J.F. Lead perturbs epidermal growth factor (EGF) modulation of intracellular calcium metabolism and collagen synthesis in clonal rat osteoblastic (ROS 17/2.8) cells. Toxicol Appl Pharmacol 1992, 114:63-70.
90. Long G.J., Rosen J.F., Pounds J.G. Lead impairs the production of osteocalcin by rat osteosarcoma (ROS 17/2.8) cells. Toxicol Appl Pharmacol 1990, 106:270-277.
91. 2+ by 19F NMR. Proc Natl Acad Sci U S A 1989, 86:5133-5135.
92. Schanne F.A.X., Dowd T.L., Gupta R.K., Rosen J.F. Effect of lead on parathyroid hormone-induced responses in rat osteoblastic osteosarcoma cells (ROS 17 2.8) using 19F-NMR. BBA - Molecular Cell Res 1990, 1054:250-255.
93. Osterode W., Reining G., Manner G., Jager J., Vierhapper H. Increased lead excretion correlates with desoxypyridinoline crosslinks in hyperthyroid patients. Thyroid 2000, 10:161-164.
94. Osterode W., Winker R., Bieglmayer C., Vierhapper H. Effects of parathyroidectomy on lead mobilization from bone in patients with primary hyperparathyroidism. Bone 2004, 35:942-947.
95. Silbergeld E.K., Schwartz J., Mahaffey K. Lead and osteoporosis: mobilization of lead from bone in postmenopausal women. Environ Res 1988, 47:79-94.
96. Carmouche J.J., Puzas J.E., Zhang X., Tiyapatanaputi P., Cory-Slechta D.A., Gelein R., et al. Lead exposure inhibits fracture healing and is associated with increased chondrogenesis, delay in cartilage mineralization, and a decrease in osteoprogenitor frequency. Environ Health Perspect 2005, 113:749-755.
97. Mañay N., Cousillas A., Heller T. Blood lead level (bll, b-Pb) in human and animal populations: b-Pb as a biological marker to environmental lead exposure cellular effects of heavy metals. Cellular effects of heavy metals 2011, 315-330. Springer, Netherlands. G. Banfalvi (Ed.).
98. Rabinowitz M.B. Toxicokinetics of bone lead. Environ Health Perspect 1991, 91:33-37.